Cargando…
Comparison of serum neurodegenerative biomarkers among hospitalized COVID‐19 patients versus non‐COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia
INTRODUCTION: Neurological complications among hospitalized COVID‐19 patients may be associated with elevated neurodegenerative biomarkers. METHODS: Among hospitalized COVID‐19 patients without a history of dementia (N = 251), we compared serum total tau (t‐tau), phosphorylated tau‐181 (p‐tau181), g...
Autores principales: | Frontera, Jennifer A., Boutajangout, Allal, Masurkar, Arjun V., Betensky, Rebecca A., Ge, Yulin, Vedvyas, Alok, Debure, Ludovic, Moreira, Andre, Lewis, Ariane, Huang, Joshua, Thawani, Sujata, Balcer, Laura, Galetta, Steven, Wisniewski, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011610/ https://www.ncbi.nlm.nih.gov/pubmed/35023610 http://dx.doi.org/10.1002/alz.12556 |
Ejemplares similares
-
Demographic and social determinants of cognitive dysfunction following hospitalization for COVID-19
por: Valdes, Eduard, et al.
Publicado: (2022) -
Reduced white matter venous density on MRI is associated with neurodegeneration and cognitive impairment in the elderly
por: Li, Chenyang, et al.
Publicado: (2022) -
Prevalence and Predictors of Prolonged Cognitive and Psychological Symptoms Following COVID-19 in the United States
por: Frontera, Jennifer A., et al.
Publicado: (2021) -
Life stressors significantly impact long-term outcomes and post-acute symptoms 12-months after COVID-19 hospitalization
por: Frontera, Jennifer A., et al.
Publicado: (2022) -
The Innate Immune System in Alzheimer's Disease
por: Boutajangout, Allal, et al.
Publicado: (2013)